References
- Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J. CSF iron, ferritin and transferring levels in restless legs syndrome. J Sleep Res 2005; 14(1): 43–7.
- Zucconi M, Ferini-Strambi L. Epidemiology and clinical findings of restless legs syndrome. Sleep Med 2004; 5(3): 293–9.
- Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4(2): 101–19.
- Drotts DL, Vinson DR. Prochlorperazine induces akathisia in emergency patients. Ann Emerg Med 1999; 34(4 Pt 1): 469–75.
- Walters AS, Aldrich MA, Allen RP, Ancoli-Israel S, Buchholz D, Chockroverty S, et al. The International Restles Legs Syndrome Study Group Mov Disord 1995; 10(5): 633–42
- Ekbom KA. Asthenia Crurum Paraesthetica (Irritable legs). Acta Med Scand 1944; 118(1–3): 197–209.
- Köves P, Szakács Z. Pathophysiology of restless leg syndrome and periodic leg movement disorder in view of the latest research findings. Ideggyogy Sz 2005; 58(5–6): 148–63.
- Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neurophysiol. 2001; 18(2): 128–47.
- Earley CJ, Allen RP, Beard JL, Connor JR. Insight into the pathophysiology of restless legs syndrome. J Neurosci Res 2000; 62(5): 623–8.
- Chen S, Ondo WG, Rao S, Li L, Chen Q, Wang Q. Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9 p. Am J Hum Genet 2004; 74(5): 876–85.
- Akpinar S. In restless legs syndrome, the neural substrates of the sensorimotor symptoms are also normally involved in upright standing posture and biped walking. Med Hypotheses 2009; 73(2): 169–76.
- Wetter TC, Stiasny K, Winkelmann J, Buhlinger A, Brandenburg U, Penzel T et al. A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 1999; 52(5): 944–50.
- Hening W, Allen R, Earley C, Kushida C, Picchietti D, Silber M. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine Review. Sleep 1999; 22(7): 970–99.
- Akpınar S. The primary restless legs syndrome pathogenesis depends on the dysfunction of EEG alpha activity. Med Hypotheses 2003; 60(2): 190–8.
- Akpinar S, Aydin H, Kutukcu Y. In restless legs syndrome, during changes in vigilance, the forced EEG shifts from alpha activity to delta or high alpha may lead to the altered states of dopamine receptor function and the symptoms. Med Hypotheses 2007; 69(2): 273–81.
- Coe HV, Hong IS. Safety of low doses of quetiapine when used for insomnia. Ann Pharmacother 2012; 46(5): 718–22.
- Cohrs S, Rodenbeck A, Guan Z, Pohlmann K, Jordan W, Meier A, et al. Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology 2004; 174(3): 421–9.
- Zarowitz BJ. Quetiapine not quiet-a-pine—not a sleeper. Geriatr Nurs. 2011; 32(1): 46–8.
- Tassniyom K, Paholpak S, Tassniyom S, Kiewyoo J. Quetiapine for primary insomnia: a double blind, randomized controlled trial. J Med Assoc Thai 2010; 93(6): 729–34.
- Kraus T, Schuld A, Pollmächer T. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol 1999; 19(5): 478–9.
- Timdahl K, Carlsson A, Stening G. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms. Hum Psychopharmacol 2001; 22(5): 315–25.
- Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless leg syndrome. Sleep Med 2003; 4(2): 121–32.
- Wetter TC, Brunner J, Bronisch T. Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry 2002; 35(3): 109–11.
- Pinninti NR, Mago R, Townsend J, Doghramji K. Periodic restless legs syndrome associated with quetiapine use: a case report. J Clin Psychopharmacol 2005; 25(6): 617–8.
- Urbano MR, Ware JC. Restless legs syndrome caused by quetiapine succesfully treated by ropinirole in 2 patients with bipolar disorder. J Clin Psychopharmacol 2008; 28(6): 704–5.
- Chou KJ, Chen PY, Huang MC. Restless legs syndrome following the combined use of quetiapine and paroxetine. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34(6): 1139–40.